Dr. Marty Makary, a Johns Hopkins surgeon and potential FDA commissioner, emphasized his commitment to sticking to science during his confirmation hearing. He aims to rebuild trust in the FDA and its regulated products. Makary addressed controversial topics such as access to the abortion pill, stating he would assess the data before making any decisions. He also discussed the cancellation of an FDA vaccine advisory committee meeting and conflicts of interest within the committee. Additionally, Makary pledged to review recent firings at the FDA and proposed solutions to high prescription drug prices and chemicals in food that may cause inflammation.
If confirmed, Makary plans to prioritize transparency, ethics, and an evidence-based approach to decision-making at the FDA. His testimony focused on the need for scientific integrity, open discourse, and addressing public health challenges such as childhood obesity and Alzheimer’s disease. Senators expressed concerns and sought clarification on various issues, and Makary assured them that he would conduct thorough assessments and work towards improving the FDA’s practices.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
